These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11362070)

  • 1. Phase III results presented on amprenavir triple combination.
    AIDS Patient Care STDS; 1998 Dec; 12(12):941-2. PubMed ID: 11362070
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary data on 141W94 reported.
    AIDS Patient Care STDS; 1998 Jan; 12(1):65-6. PubMed ID: 11361894
    [No Abstract]   [Full Text] [Related]  

  • 3. Amprenavir study results released.
    AIDS Patient Care STDS; 1999 Dec; 13(12):754. PubMed ID: 10743545
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II/III Trials of Viracept start.
    AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361632
    [No Abstract]   [Full Text] [Related]  

  • 5. New drugs: amprenavir and abacavir.
    TreatmentUpdate; 1998 Apr; 10(2):3-4. PubMed ID: 11365435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amprenavir approved.
    AIDS Patient Care STDS; 1999 Jul; 13(7):438. PubMed ID: 10870601
    [No Abstract]   [Full Text] [Related]  

  • 7. [HIV: to administer protease inhibitors early].
    Dtsch Med Wochenschr; 1996 Dec; 121(49):A49. PubMed ID: 8998916
    [No Abstract]   [Full Text] [Related]  

  • 8. Amping amprenavir with ritonavir.
    TreatmentUpdate; 2001; 12(12):10. PubMed ID: 11570075
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral therapy: how simple can you get?
    Gilden D
    GMHC Treat Issues; 1998 Nov; 12(11):3-7. PubMed ID: 11365906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head-to-head study of protease inhibitors.
    AIDS Patient Care STDS; 1998 Jan; 12(1):63-4. PubMed ID: 11361890
    [No Abstract]   [Full Text] [Related]  

  • 11. New treatment options.
    Fornataro K; Jefferys R
    Body Posit; 1999 Jun; 12(6):11-2. PubMed ID: 11367013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy danger.
    Posit Aware; 1998; 9(5):18. PubMed ID: 11365886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double protease inhibitor regimens with amprenavir show promise.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962
    [No Abstract]   [Full Text] [Related]  

  • 14. 141 (Vertex-478).
    Baker R; Bowers M
    BETA; 1997 Mar; ():5. PubMed ID: 11364529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV: less resistance due to combined treatment].
    Dtsch Med Wochenschr; 1996 Dec; 121(49):A47-8. PubMed ID: 8998914
    [No Abstract]   [Full Text] [Related]  

  • 16. [Individualized therapy with fosamprenavir/r. A PI suitable in liver problems].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():60-1. PubMed ID: 19031566
    [No Abstract]   [Full Text] [Related]  

  • 17. ICAAC update.
    Coppedge B
    STEP Perspect; 1996; 8(3):15-6. PubMed ID: 11364265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet dysfunction as the cause of spontaneous bleeding in two haemophilic patients taking HIV protease inhibitors.
    Pollmann H; Richter H; Jürgens H
    Thromb Haemost; 1998 Jun; 79(6):1213-4. PubMed ID: 9657450
    [No Abstract]   [Full Text] [Related]  

  • 19. Drifting agenda for federal treatment research.
    Huff B
    GMHC Treat Issues; 2001 May; 15(5):1-4. PubMed ID: 11548299
    [No Abstract]   [Full Text] [Related]  

  • 20. Trials for protease failure.
    Posit Aware; 1998; 9(5):16-7. PubMed ID: 11365884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.